The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Novikova M.S.

Sechenov First Moscow State Medical University (Sechenov University)

Zaharov V.V.

Sechenov First Moscow State Medical University (Sechenov University)

Predictors of the efficacy of non-drug treatments for non-dementia vascular cognitive impairment

Authors:

Novikova M.S., Zaharov V.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(5): 83‑88

DOI: 10.17116/jnevro202312305183

Read: 1548 times

Download PDF (RU)
Contact the author
Table of contents

PREDICTORS OF THE EFFICACY OF NON-DRUG TREATMENTS FOR NON-DEMENTIA VASCULAR COGNITIVE IMPAIRMENT
PREDICTORS OF THE EFFICACY OF NON-DRUG TREATMENTS FOR NON-DEMENTIA VASCULAR COGNITIVE IMPAIRMENT

To cite this article:

Novikova MS, Zaharov VV. Predictors of the efficacy of non-drug treatments for non-dementia vascular cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(5):83‑88. (In Russ.)
https://doi.org/10.17116/jnevro202312305183

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The role of biomarkers of endo­thelial dysfunction in predicting the progression of mild cognitive impairment in patients with cardiovascular risk factors. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):88-95
A comparative asse­ssment of neurochemical and neurophysiological para­meters of cardiac surgery patients who unde­rwent different versions of multitasking cognitive training. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):62-68
Curcumin-induced increased reti­nal fluorescence as a new method in the early diagnosis of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):19-25
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
Treatment features of patients with vascular cognitive impairments. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):69-76
Novel prospects for early diagnosis of cognitive impairment using Eye-tracking technology. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):13-20
Cognitive reha­bilitation technology using a combination of postural training and simu­ltaneous cognitive task in prevention of cognitive impairment after coro­nary artery bypass grafting. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):418-427
Abstract:

OBJECTIVE

To study the predictors of the efficacy of non-drug multimodal therapy in the treatment of mild vascular cognitive impairment.

MATERIAL AND METHODS

Thirty patients with mild vascular cognitive impairment, under the supervision of their physician, received a 1-month non-drug treatment program including cognitive training, detailed recommendations for physical activity, and dietary planning.

RESULTS

After the end of the course of treatment, improvements in the MoCa test were achieved by 22 patients (73%), which made up Group 1. In the remaining 8 patients, the treatment had no effect (Group 2). In Group 1, the dynamics of the MoCa test averaged 1.7±0.9, in the Group 2 it was (–0.4)±0.5. Patients of Group 1 had a significantly lower level of education (10.9±2.3) compared with Group 2 (14.9±2.0), a higher initial MoCa score, and a less pronounced white matter lesion on the Fazekas scale. After the regression analysis, the level of education (B –0.999, p<0.05) and white matter damage (B –2.761, p<0.01) were significant predictors.

CONCLUSION

When using non-drug multimodal therapy in the treatment of mild vascular cognitive impairment, lower levels of education and a lower degree of white matter vascular damage are reliable predictors of treatment efficacy.

Keywords:

moderate vascular cognitive impairment
cognitive training
non-drug therapies
treatment predictors

Authors:

Novikova M.S.

Sechenov First Moscow State Medical University (Sechenov University)

Zaharov V.V.

Sechenov First Moscow State Medical University (Sechenov University)

Received:

09.11.2022

Accepted:

18.01.2023

Close metadata

References:

  1. Jongsiriyanyong S, Limpawattana P. Mild Cognitive Impairment in Clinical Practice: A Review Article. Am J Alzheimers Dis Other Demen. 2018;33(8):500-507.  https://doi.org/10.1177/1533317518791401
  2. Starchina YuA. Non-dementia cognitive impairment: a modern view of the problem. Neurology, Neuropsychiatry, Psychosomatics. 2017;9(2):71-76. (In Russ.). https://doi.org/10.14412/2074-2711-2017-2-71-76
  3. Yakhno NN, Lokshina AB, Zakharov VV, et al. Syndrome of moderate cognitive impairment in the Russian population. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2019;119(5):179. (In Russ.). https://doi.org/10.17116/jnevro201911905S
  4. Amieva H, Robert PH, Grandoulier AS, et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. Int Psychogeriatr. 2016;28(5):707-717.  https://doi.org/10.1017/S1041610215001830
  5. Singh B, Parsaik AK, Mielke MM, et al. Association of mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;39(2):271-282.  https://doi.org/10.3233/JAD-130830
  6. Solfrizzi V, Custodero C, Lozupone M, et al. Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review. J Alzheimers Dis. 2017;59(3):815-849.  https://doi.org/10.3233/JAD-170248
  7. Kessels RP, Eikelboom WS, Schaapsmeerders P, et al. Effect of Formal Education on Vascular Cognitive Impairment after Stroke: A Meta-analysis and Study in Young-Stroke Patients. J Int Neuropsychol Soc. 2017;23(3):223-238.  https://doi.org/10.1017/S1355617716001016
  8. Shimada H, Doi T, Lee S, Makizako H. Reversible predictors of reversion from mild cognitive impairment to normal cognition: a 4-year longitudinal study. Alzheimers Res Ther. 2019;11(1):24.  https://doi.org/10.1186/s13195-019-0480-5
  9. Pandya SY, Lacritz LH, Weiner MF, et al. Predictors of reversion from mild cognitive impairment to normal cognition. Dement Geriatr Cogn Disord. 2017;43(3-4):204-214.  https://doi.org/10.1159/000456070
  10. Osone A, Arai R, Hakamada R, Shimoda K. Impact of lifestyle-related disease on conversion and reversion in patients with mild cognitive impairment: after 12 months of follow-up. Int J Geriatr Psychiatry. 2016;31(7):740-748.  https://doi.org/10.1002/gps.4386
  11. Osone A, Arai R, Hakamada R, Shimoda K. Cognitive and brain reserve in conversion and reversion in patients with mild cognitive impairment over 12 months of follow-up. J Clin Exp Neuropsychol. 2016;38(10):1084-1093. https://doi.org/10.1080/13803395.2016.1191620
  12. Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255-2263. https://doi.org/10.1016/S0140-6736(15)60461-5
  13. Roheger M, Kalbe E, Corbett A, et al. Predictors of activities of daily living in heathy older adults: Who benefits most from online cognitive training? Brain Behav. 2021;11(11):e2388. https://doi.org/10.1002/brb3.2388
  14. Shigihara Y, Hoshi H, Poza J, et al. Predicting the outcome of non-pharmacological treatment for patients with dementia-related mild cognitive impairment. Aging (Albany NY). 2020;12(23):24101-24116. https://doi.org/10.18632/aging.202270
  15. Hsu TJ, Tsai HT, Hwang AC, et al. Predictors of non-pharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia. Geriatr Gerontol Int. 2017;(17 suppl 1):28-35.  https://doi.org/10.1111/ggi.13037
  16. Roheger M, Kalbe E, Corbett A, et al. Predictors of changes after reasoning training in healthy adults. Brain Behav. 2020;10(12):e01861. https://doi.org/10.1002/brb3.1861
  17. Roheger M, Kalbe E, Corbett A, et al. Lower cognitive baseline scores predict cognitive training success after 6 months in healthy older adults: Results of an online RCT. Int J Geriatr Psychiatry. 2020;35(9):1000-1008. https://doi.org/10.1002/gps.5322
  18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Association, 2013).
  19. Morris MC, Tangney CC, Wang Y, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015;11(9):1015-1022. https://doi.org/10.1016/j.jalz.2015.04.011
  20. Ciesielska N, Sokołowski R, Mazur E, et al. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol. 2016;50(5):1039-1052. https://doi.org/10.12740/PP/45368
  21. Meng X, D’Arcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One. 2012;7(6):e38268. https://doi.org/10.1371/journal.pone.0038268
  22. Xu W, Tan L, Wang HF, et al. Education and Risk of Dementia: Dose-Response Meta-Analysis of Prospective Cohort Studies. Mol Neurobiol. 2016;53(5):3113-3123. https://doi.org/10.1007/s12035-015-9211-5
  23. Park S, Ryu SH, Yoo Y, et al. Neural predictors of cognitive improvement by multi-strategic memory training based on metamemory in older adults with subjective memory complaints. Sci Rep. 2018;8(1):1095. https://doi.org/10.1038/s41598-018-19390-2
  24. Clark DO, Xu H, Unverzagt FW, Hendrie H. Does targeted cognitive training reduce educational disparities in cognitive function among cognitively normal older adults? Int J Geriatr Psychiatry. 2016;31(7):809-817.  https://doi.org/10.1002/gps.4395
  25. Middelstädt J, Folkerts AK, Blawath S, Kalbe E. Cognitive Stimulation for People with Dementia in Long-Term Care Facilities: Baseline Cognitive Level Predicts Cognitive Gains, Moderated by Depression. J Alzheimers Dis. 2016;54(1):253-268.  https://doi.org/10.3233/JAD-160181
  26. DeTore NR, Mueser KT, Byrd JA, McGurk SR. Cognitive functioning as a predictor of response to comprehensive cognitive remediation. J Psychiatr Res. 2019;113:117-124.  https://doi.org/10.1016/j.jpsychires.2019.03.012
  27. Moscoso D, Martín F. Vocabulary, Grammar, Sex, and Aging. Cognitive Science. 2017;41(4):950-975.  https://doi.org/10.1111/cogs.12367
  28. Chen X, Duan L, Han Y, et al. Predictors for vascular cognitive impairment in stroke patients. BMC Neurol. 2016;16:115.  https://doi.org/10.1186/s12883-016-0638-8
  29. Baker LD, Frank LL, Foster-Schubert K, et al. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol. 2010;67(1):71-79.  https://doi.org/10.1001/archneurol.2009.307
  30. Wang Y, Yang Y, Wang T, et al. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease. J Stroke Cerebrovasc Dis. 2020;29(12):105275. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105275
  31. Boutzoukas EM, O’Shea A, Kraft JN, et al. Higher white matter hyperintensity load adversely affects pre-post proximal cognitive training performance in healthy older adults. Geroscience. 2022;44(3):1441-1455. https://doi.org/10.1007/s11357-022-00538-y
  32. Innes KE, Selfe TK, Khalsa DS, Kandati S. Meditation and Music Improve Memory and Cognitive Function in Adults with Subjective Cognitive Decline: A Pilot Randomized Controlled Trial. J Alzheimers Dis. 2017;56(3):899-916.  https://doi.org/10.3233/JAD-160867
  • Falls in elderly and senile patients. Federation Health Ministry Clinical recommendations. 2020. (In Russ.). https://cr.rosminzdrav.ru/#!/recomend/1030
  • Chronic pain in elderly and senile patients. Russian Federation Health Ministry Clinical recommendations. 2020. (In Russ.). https://cr.rosminzdrav.ru/#!/recomend/1033
  • Clinical recommendations of the Ministry of Health of Russia «Gonarthrosis». 2021. (In Russ.). https://cr.minzdrav.gov.ru/recomend/667_1
  • Clinical recommendations of the Ministry of Health of Russia «Coxarthrosis». 2021. (In Russ.). https://cr.minzdrav.gov.ru/recomend/666_1
  • Iovu M, Dumais G, du Souich P. Anti-inflammatory activity of chondroitin sulfate. Osteoart Cart. 2008;16 Suppl 3:S14-18.  https://doi.org/10.1016/j.joca.2008.06.008
  • Du Souich P, Garcia A,Verges J, Montell E. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med. 2009;3(8A):1451-1463. https://doi.org/10.1111/j.1582-4934.2009.00826.x
  • de Abajo F, Gil M, Garcia Poza P, et al. Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study. Pharmacoepidemiol Drug Saf. 2014;23:1128-1138. https://doi.org/10.1002/pds.3617
  • King D, Xiang J. Glucosamine/Chondroitin and Mortality in a US NHANES Cohort. J Am Board Fam Med. 2020;33(6):842-847.  https://doi.org/10.3122/jabfm.2020.06.200110
  • Bell G, Kantor E, Lampe J, et al. Use of glucosamine and chondroitin in relation to mortality. Eur J Epidemiol. 2012;27(8):593-603.  https://doi.org/10.1007/s10654-012-9714-6
  • Morrison L. Reduction of ischemic coronary heart disease by chondroitin sulfate. Angiology. 1971;22(3):165-174.  https://doi.org/10.1177/000331977102200308
  • Morrison L, Enrick N. Coronary Heart Disease: Reduction of Death Rate By Chondroitin Sulfate. Angiology. 1973;24(5):269-287.  https://doi.org/10.1177/000331977302400503
  • Nakazawa K, Murata K. Comparative study of the effects of chondroitin sulfate isomers on atherosclerotic subjects. Clinical Trial. Z Alternsforsch. 1979;34(2):153-159. 
  • Mazzucchelli R, Rodrı´guez-Martı´n S, Garcı´a-Vadillo A, et al. Risk of acute myocardial infarction among new users of chondroitin sulfate: A nested case-control study. PLoS ONE. 2021;16(7):e0253932. https://doi.org/10.1371/journal.pone.0253932
  • Melgar-Lesmes P, Sánchez-Herrero A, Lozano-Juan F, et al. Chondroitin Sulphate Attenuates Atherosclerosis in ApoE Knockout Mice Involving Cellular Regulation of the Inflammatory Response. Thromb. Haemost. 2018;118(7):1329-1339. https://doi.org/10.1055/s-0038-1657753
  • Williams K, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15(5):551-561.  https://doi.org/10.1161/01.atv.15.5.551
  • Adhikara I, Yagi K, Mayasari D, et al. Chondroitin Sulfate Nacetylgalactosaminyltransferase-2 Impacts Foam Cell Formation and Atherosclerosis by Altering Macrophage Glycosaminoglycan Chain. Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):1076-1091. https://doi.org/10.1161/ATVBAHA.120.315789
  • Bell J, Rhind S, Di Battista A, et al. Biomarkers of glycocalyx injury are associated with delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage: a case series supporting a new hypothesis. Neurocrit Care. 2016;26(3):339-347.  https://doi.org/10.1007/s12028-016-0357-4
  • Nuytemansa K, Ortelb T, Gomeza L, et al. Variants in chondroitin sulfate metabolism genes in thrombotic storm. Thromb Res. 2018;161:43-51.  https://doi.org/10.1016/j.thromres.2017.11.016
  • Ye J, Esmon C, Johnson A. The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin. J Biol Chem. 1993;268(4):2373-2379.
  • McGee M, Wagner W. Chondroitin Sulfate Anticoagulant Activity Is Linked to Water Transfer Relevance to Proteoglycan Structure in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23(10):1921-1927. https://doi.org/10.1161/01.ATV.0000090673.96120.67
  • Moroudas A, Weinberg P, Parker K, Winlove C. The distribution and diffusion of small ions in chondroitin sulfate, hyaluronate and some proteoglycans solutions. Biophys Chem. 1988;32(2-3):257-270.  https://doi.org/10.1016/0301-4622(88)87012-1
    • Contact the author
    Email
    Message
    The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

    Email Confirmation

    An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

    Email Confirmation

    Contact us
    If you have any questions, complaints or suggestions, please use this feedback form.
    Email
    Message
    The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
    Submit Application

    You can become an author of one of our magazines, send a request and we will consider it in during the day.

    Name
    Phone
    E-mail
    Message
    Login
    Registration
    E-mail
    Password
    Forgot Password?

    Log in to the site using your account in one of the services

    Password recovery
    E-mail
    Login
    Register

    We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.